Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 4, 2012, Pages

  Daoni, Esorom ^a   Kitur, Urarang ^a   Parunga, Apa ^a   Ndenzako, Fabian ^b   Lloyd, Agatha ^b   Yu, Dongbao ^b  

^a National Department of Health   (Papua New Guinea)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPUA NEW GUINEA; PATIENT MONITORING; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MEDICATION ADHERENCE; NATIONAL HEALTH PROGRAMS; PAPUA NEW GUINEA; POPULATION SURVEILLANCE; WORLD HEALTH ORGANIZATION;

EID: 84860357726     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir994     Document Type: Article

References (6)

1. Philippine National AIDS Council Secretariat. UNGASS 2010 country progress report. Papua New Guinea, 2010.
2. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-10. (Pubitemid 44142772)
3. Bennett D, Bertagnolio S, Sutherland D, Gilks CF. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008; 13(Suppl 2):1-13. (Pubitemid 352019085)
4. Jordan M, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites. Antivir Ther 2008; 13(Suppl 2):15-23. (Pubitemid 352019086)
5. World Health Organization. HIV drug resistance early warning indicators. Geneva, Switzerland: WHO, 2010.
6. Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008; 13(Suppl 2): 25-36. (Pubitemid 352019087)